Sadaf Agahi

Dr. Sadaf Agahi

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
NTNahid Tofigh
Nahid Tofigh
SASadaf Agahi
Sadaf Agahi
GRGholamhossein Riazi
Gholamhossein Riazi
MMMahboobeh Ghalamkar Moazzam
Mahboobeh Ghalamkar Moazzam
KSKoorosh Shahpasand
Koorosh Shahpasand
Alzheimer’s disease (AD) is a neurodegenerative disorder with no effective treatments. Hyperphosphorylation of tau protein contributes to neurodegeneration in AD. Previous studies have identified pT231-tau in the cis conformation as an early driver of neurodegeneration in tauopathy models. Here, we identify a novel neurotoxic pT231-tau conformer in human AD neurons, distinct from both cis and trans conformations, which we propose as the gauche pT231-tau conformer. Notably, levels of this conformer were elevated in neurons subjected to aging-associated stress. In order to confirm the stress, we examined p21 accumulation in both human iPSC-derived and mouse cortical neurons under aging stress. Targeted elimination of the gauche pT231-tau conformer mitigated neurodegeneration in human AD cultures. These findings suggest the gauche pT231-tau conformer plays a key role in tau-mediated neurodegeneration and may be a potential therapeutic target for AD.

10 August 2026 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
AAAtieh Amouzegar
Atieh Amouzegar
SASadaf Agahi
Sadaf Agahi
SMSafdar Masoumi
Safdar Masoumi
MTMohamadamin Tarighat-Payma
Mohamadamin Tarighat-Payma
MHMohammadjavad Honarvar
Mohammadjavad Honarvar
LMLadan Mehran
Ladan Mehran

29 April 2026 in Sage Open Aging
Verified
Journal Article
Open access
SMSeyede Salehe Mortazavi
Seyede Salehe Mortazavi
MSMohsen Shati
Mohsen Shati
ENEnsiyeh Najjari
Ensiyeh Najjari
MFMobin Fathi
Mobin Fathi
FTFariba Tabrizi
Fariba Tabrizi
SASadaf Agahi
Sadaf Agahi
Background: The Geriatric Depression Scale (GDS) is widely used to screen depression in older adults, yet culturally adapted brief forms require validation. Objective: This study aimed to evaluate the validity and reliability of the Persian Five-Item Geriatric Depression Scale (GDS-5) to ensure its suitability for accurate and efficient depression screening among Iranian older adults. Methods: This cross-sectional study evaluated the psychometric properties of the Persian Five-Item GDS (GDS-5) in 200 Iranian older adults. Structural validity was examined using Exploratory Factor Analysis (EFA). Concurrent validity, test–retest reliability, and diagnostic accuracy were assessed using standard correlation and ROC analyses. Results: EFA supported a coherent one-factor structure. The GDS-5 showed strong concurrent validity with the CES-D ( r = .71, p < .001) and excellent test–retest reliability (ICC = 0.809, p < .001). ROC analysis demonstrated high diagnostic accuracy (AUC = 0.924). At the optimal cutoff, sensitivity was 0.98 and specificity was 0.77. Conclusion: Overall, the present study demonstrates that the Persian version of the GDS-5 is a valid, reliable, and diagnostically accurate screening instrument for depressive symptoms among Iranian older adults. Future research should focus on validating the instrument in diverse settings (e.g., primary care clinics, long-term care facilities) and utilizing a wider sample with diverse sociodemographic characteristics to improve generalizability.

1 July 2026 in RISE Health Research Journal
Verified
Journal Article
Open access
Shervin AssariShervin Assari
Shervin Assari
SASadaf Agahi
Sadaf Agahi
SMSeyede Salehe Mortazavi
Seyede Salehe Mortazavi
FTFariba Tabrizi
Fariba Tabrizi
FSFarshad Sharifi
Farshad Sharifi
MSMohsen Shati
Mohsen Shati
Health has traditionally been measured by the presence or absence of disease. However, global initiatives, such as those from the World Health Organization (WHO), emphasize that health also includes functionality, capacity, well-being, and quality of life. Patient-reported outcomes (PROs) capture these dimensions directly from older adults and provide insights that complement clinical and biological markers. Initiatives such as Patient-Centered Outcomes Research Institute similarly promote PROs as core research outcomes. This perspective highlights the role of PROs in geriatric and aging research and presents a conceptual framework linking social determinants, disease burden, and patient-reported health in predicting outcomes. We outline priority research questions, identifying relevant international data sets, and discuss methodological approaches, including nested survival models, event-anchored mixed-effect models, and measurement invariance testing, to study how PROs evolve across populations and over time. Advancing these approaches may help move aging research toward a more holistic, patient-centered model of health.

29 October 2025 in Cephalalgia Reports
Verified
Journal Article
Open access
ADAzam Ahangar Darabi
Azam Ahangar Darabi
SASadaf Agahi
Sadaf Agahi
AKAli Kermanpour
Ali Kermanpour
ANAhmadreza Niavarani
Ahmadreza Niavarani
NMNazila Malekian
Nazila Malekian
SASiamak Abdi
Siamak Abdi
Background: : The trigemino-cerebrovascular system is recognized as a key anatomical structure playing a crucial role in the pathophysiology of migraine. It is also well established that the herpes simplex virus (HSV) resides within the trigeminal ganglion. Previous studies have emphasized the role of infectious inflammatory conditions in migraine. We hypothesize the potential involvement of HSV infection in migraine pathology. Method: This study employed a case–control design to investigate the association between plasma HSV type 1 and 2 IgM and IgG antibodies and migraine. A total of 111 subjects were selected from patients referred to the Neurology Clinic at Tehran's Shariati Hospital, including 57 migraine cases and 54 healthy controls. Participants completed questionnaires covering demographic data and migraine severity. Blood samples were collected from all participants, and HSV-1 and HSV-2 IgM and IgG antibody levels were assessed using the VIRCELL Herpes Simplex Virus I and II ELISA IgG/IgM kit. Results: The prevalence of HSV-1 seropositivity was 70.18% (40 of 57) in participants with migraine, which was significantly higher compared to 51.85% (28 of 54) in the control group ( p = 0.48). HSV-1 seropositivity was associated with a 2.185-fold increase in the odds of having migraine (OR = 2.185, 95% CI: 1.002–4.762). However, the quantitative analysis of HSV-1 IgG levels in relation to migraine severity scores did not show statistical significance. Conclusion: The observed association strengthens the hypothesis of the potential role of HSV in the pathophysiology of migraine. Our findings suggest that targeting HSV-1 could be a promising strategy for developing new treatments for migraine prophylaxis.

1 January 2025 in Cardiology Research and Practice
Verified
Journal Article
Open access
SASadaf Agahi
Sadaf Agahi
EGEhsan Goudarzi
Ehsan Goudarzi
ASAkram Sardari
Akram Sardari
RBRoya Sattarzadeh Badkoubeh
Roya Sattarzadeh Badkoubeh
MEMohammad Reza Eftekhari
Mohammad Reza Eftekhari
FLFarnoosh Larti
Farnoosh Larti
Background: Determining the normal ranges of the aortic dimension is essential in various populations. In this study, we aim to define the normal ranges for the sinus of Valsalva (SoV), the sinotubular junction (STJ), and the ascending aorta (AA) diameters using the Imam Khomeini Hospital Complex (IKHC) data registry of Iranian adults. Methods: This study was conducted on 2269 adult participants with left ventricular ejection fraction (LVEF) of more than 50%. Echocardiographic measurements were taken at the SoV, STJ, and AA levels. Subjects with any valvular stenosis and more than moderate insufficiency were excluded. Results: The normal range of SoV was found to be 24.5–38.9 mm in males and 21.7–34.9 mm in females. Additionally, the STJ diameters ranged from 19.7 to 32.5 mm and 18.0 to 29.6 mm in males and females, respectively. The AA measurements showed significant differences between sexes, ranging from 23.74 to 38.02 mm in males and 21.45 to 36.53 mm in females. Results also indicated that for every 10‐year increase in age, the diameters of SoV, STJ, and AA increased by approximately 1.0, 0.8, and 1.6 mm, respectively. Conclusion: This study provided detailed echocardiographic reference values for aortic dimensions in the Iranian population and compared them across various age groups, genders, and body mass index (BMI) categories. Also, the findings emphasize the impact of aging on aortic values. The limited external validity of our single‐center, hospital‐based study suggests that future multicenter research is necessary to confirm our findings and improve their generalizability.